Frozen cells could unlock future medical breakthroughs
NCT ID NCT07321028
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This laboratory study looks at how freezing and thawing affects human cells. Researchers will test different freezing methods on cell samples to see which keeps the most cells alive and healthy. The goal is to improve cell storage for future medical use. No human participants are involved—only donated cell samples.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Cryopreservation procedure (freezing and thawing of human cells in a lab)
- What this could lead to
- If successful, this could help develop better methods for storing cells for future therapies or research.
- What could go wrong
- This is an early lab study on cells, not people. Results may not translate to real-world medical treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Early phase 1
The earliest testing in people: a first look at safety, in a very small group.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2025
- Expected to finish
-
Dec 2066
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * This study does not enroll human participants. Eligibility applies only to human-derived cell samples. * Samples must be de-identified prior to receipt. * Samples must demonstrate ≥90% viability at pre-freeze assessment. * Samples must be free of contamination (bacterial, fungal, mycoplasma). * Samples must meet chain-of-custody and biospecimen compliance requirements. Exclusion Criteria: * No human participants will be enrolled or contacted. * Any specimen containing identifiable private information. * Samples with inadequate quality, contamination, or compromised viability. * Samples obtained without appropriate donor consent or de-identification certification.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Biomechanical injury modeling (in-vitro) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Truway Health, Inc. , View 34, 401 E 34th Street, S11P, New York, NY 10016
New York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.